title: [Performance of uteroplacental perfusion in contrast to hormone-analytic investigations in intrauterine retardation and under the influence of intravenous long-term application of heparin (author's transl)].
abstract: The digital estimation of utero-placental circulation by means of nuclear-medical examinations with help of 113 m In-Cl and regarding to the "region of interest" gives no depositions in cases with an intrauterine retardation. This concerns the activity as well in the placenta as in the uterus too. Exceptions represents intrauterine retardations on the base of heaviness EPH-gestosis and placenta previa. Herewith the rise of activity corresponds with the thickness in the III. trimester of pregnancy. A treatment about several weeks with Hepain under bed conditions leads to no proofed influence of the uteroplacental circulation, on the contrary to a rise of estriol and HPL-values, meaning a improvement of placental performance. The estimation of the utero-placental circulation by means of nuclear-medical examinations is situated to the problem of fetal condition by EPH-gestosis, placenta previa and other.
mesh_terms: D004964:Estriol / Q000097:blood; D005260:Female; D005317:Fetal Growth Retardation / Q000000981:diagnostic imaging; D006493:Heparin / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D010920:Placenta / Q000098:blood supply*; D010923:Placenta Previa / Q000503:physiopathology; D010928:Placental Lactogen / Q000097:blood; D011225:Pre-Eclampsia / Q000503:physiopathology; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011296:Prenatal Diagnosis / Q000379:methods; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000187:drug effects; D014599:Uterus / Q000098:blood supply*
chemical_list: D006493:Heparin; D010928:Placental Lactogen; D004964:Estriol
vernacular_title: Das Verhalten der utero-plazentaren Durchblutung in Gegenüberstellung zu hormonanalytischen Untersuchungen bei der intrauterinen Retardierung und unter dem Einfluss einer intravenösen Langzeitheparinapplikation.